Skip to main content

Table 1 Clinical values at baseline and 1-year follow-up

From: Correlation of active contact location with weight gain after subthalamic nucleus deep brain stimulation: a case series

  Baseline 1-year Follow-up p-value
Bodyweight 55.8 (49.7–63.6) 60.7 (53.1–69.6) < 0.001
BMI 23.1 (20.1–25.7) 24.5 (22.0–29.1) < 0.001
UPDRS part III (MedOn) 14 (10–18) 8 (4.5–19.3) 0.13
UPDRS part III (MedOff) 40 (33.8–44.3) 16 (11.8–23) < 0.001
UPDRS part IV (items 32 + 33) 1.5 (0–4) 1 (0–2.25) 0.12
MMSE 29 (27.8–30) 29 (28–30) 0.3
FAB 14.5 (14.5–17.5) 15.5 (13.8–17.3) 0.023
Apathy scale 13.5 (7.5–16) 14 (4.8–16.3) 0.47
PHQ-9 5 (4–8) 4 (0–7.8) 0.43
LEDD 689 (363–748.5) 418.5 (297.3–656.3) 0.085
  1. Scores are reported as the median (interquartile range)
  2. BMI body mass index; FAB Frontal Assessment Battery; LEDD levodopa-equivalent daily dose; MedOff a condition without intaking medication; MedOn a condition requiring intaking medication. MMSE Mini Mental State Examination; PHQ-9 Patient Health Questionnaire-9; UPDRS Unified Parkinson’s Disease Rating Scale